Article
Trial results demonstrated statistically significant improvement in the prespecified primary endpoint in BCVA at 13 months in the PBM treatment group over the sham-treatment group.
Article
Research to Prevent Blindness will launch the RPB/David L. Epstein Career Advancement Award in Glaucoma Research, sponsored by Aerie Pharmaceuticals.
Article
The nonprofit has continually reached for new heights in the fight against avoidable blindness.
Video
Review treatment options for both early and late complications of cataract surgery.
Article
VUITY, developed by Allergan, is the first and only FDA-approved eye drop to treat presbyopia
Article
Susvimo's new therapeutic approach for wet AMD may help patients maintain their vision with as few as 2 treatments per year